These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11312003)

  • 1. Collagen minipellet as a controlled release delivery system for tetanus and diphtheria toxoid.
    Higaki M; Azechi Y; Takase T; Igarashi R; Nagahara S; Sano A; Fujioka K; Nakagawa N; Aizawa C; Mizushima Y
    Vaccine; 2001 Apr; 19(23-24):3091-6. PubMed ID: 11312003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.
    Gupta RK; Griffin P; Rivera R; Siber GR
    Dev Biol Stand; 1998; 92():277-87. PubMed ID: 9554282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pluronic F127-based systemic vaccine delivery systems.
    Coeshott CM; Smithson SL; Verderber E; Samaniego A; Blonder JM; Rosenthal GJ; Westerink MA
    Vaccine; 2004 Jun; 22(19):2396-405. PubMed ID: 15193401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide.
    Men Y; Thomasin C; Merkle HP; Gander B; Corradin G
    Vaccine; 1995 May; 13(7):683-9. PubMed ID: 7668038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of IRIV- versus alum-adjuvanted diphtheria and tetanus toxoid vaccines in influenza primed mice.
    Zurbriggen R; Glück R
    Vaccine; 1999 Mar; 17(11-12):1301-5. PubMed ID: 10195764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral immunization against diphtheria and tetanus infections by fluid diphtheria and tetanus toxoids.
    Mirchamsy H; Hamedi M; Fateh G; Sassani A
    Vaccine; 1994 Oct; 12(13):1167-72. PubMed ID: 7530887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine.
    Singh M; Li XM; Wang H; McGee JP; Zamb T; Koff W; Wang CY; O'Hagan DT
    Infect Immun; 1997 May; 65(5):1716-21. PubMed ID: 9125552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant properties of non-phospholipid liposomes (Novasomes) in experimental animals for human vaccine antigens.
    Gupta RK; Varanelli CL; Griffin P; Wallach DF; Siber GR
    Vaccine; 1996 Feb; 14(3):219-25. PubMed ID: 8920703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Kozuka S; Taniguchi T; Matano K; Maeyama J; Komiya T; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 1999 Nov; 18(7-8):743-51. PubMed ID: 10547435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of alum in improving the immunogenicity of biodegradable polymer particle entrapped antigens.
    Kanchan V; Katare YK; Panda AK
    Eur J Pharm Sci; 2009 Aug; 38(1):18-28. PubMed ID: 19467323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvanticity of pGPL-Mc and LRS in the immune responses of monkeys to oral immunization with diphtheria and tetanus toxoids.
    Mirchamsy H; Neway T; Hamedi M; Pilet C
    Comp Immunol Microbiol Infect Dis; 1997 Jan; 20(1):13-20. PubMed ID: 9023036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulating role of toxoids-laden liposomes in oral immunization against diphtheria and tetanus infections.
    Mirchamsy H; Manhouri H; Hamedi M; Ahourai P; Fateh G; Hamzeloo Z
    Biologicals; 1996 Dec; 24(4):343-50. PubMed ID: 9088551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies.
    Yasuda Y; Isaka M; Taniguchi T; Zhao Y; Matano K; Matsui H; Morokuma K; Maeyama J; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Jun; 21(21-22):2954-63. PubMed ID: 12798639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro induction of a diphtheria toxoid specific antibody response in human peripheral blood lymphocytes cultivated in the presence of diphtheria toxoid.
    Loggen HG; Kreeftenberg JG
    J Biol Stand; 1989 Oct; 17(4):311-9. PubMed ID: 2613706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the production of antidiphtheria and antitetanus antitoxins after injections of anatoxins combined with pertussis vaccine].
    Cabau N
    Rev Immunol Ther Antimicrob; 1968; 32(6):375-82. PubMed ID: 5752616
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term immunogenicity and immunologic priming of animals to pulsed controlled-release system for tetanus toxoid vaccine delivery].
    He Y; Chen ZH; Wei SL
    Yao Xue Xue Bao; 2001 Sep; 36(9):695-8. PubMed ID: 12580111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the adequate composition of diphtheria and tetanus toxoids-with reference to the amounts of toxoids and aluminum adjuvant.
    Someya S; Mizuhara H; Murata R; Kurokawa M
    Jpn J Med Sci Biol; 1981 Feb; 34(1):21-35. PubMed ID: 7265558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negatively charged liposomes as immunological adjuvant for tetanus and diphtheria toxoids.
    Popescu C; Durbaca S; Ivanov D
    Roum Arch Microbiol Immunol; 1998; 57(3-4):255-61. PubMed ID: 11845437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of nanoparticle adjuvants to potentiate the immune response against diphtheria toxoid.
    Alshanqiti FM; Al-Masaudi SB; Al-Hejin AM; El-Baky NA; Redwan EM
    Hum Antibodies; 2018 Feb; 26(2):75-85. PubMed ID: 29171990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines.
    Mark A; Björkstén B; Granström M
    Vaccine; 1995 May; 13(7):669-73. PubMed ID: 7668036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.